<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02721654</url>
  </required_header>
  <id_info>
    <org_study_id>GI-CCT7587</org_study_id>
    <secondary_id>U1111-1178-8334</secondary_id>
    <nct_id>NCT02721654</nct_id>
  </id_info>
  <brief_title>Plasma-Lyte 148® versUs Saline Study</brief_title>
  <acronym>PLUS</acronym>
  <official_title>Comparison of Plasmalyte 148® and Saline for Fluid Resuscitation and Intravenous Fluid Therapy in Critically Ill Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The George Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Australian and New Zealand Intensive Care Society Clinical Trials Group</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Baxter Healthcare Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>The George Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of PLUS is to conduct a multi-centre, blinded, randomised, controlled trial (RCT) to&#xD;
      determine whether fluid resuscitation and therapy with a &quot;balanced&quot; crystalloid solution&#xD;
      (Plasma-Lyte 148®) decreases 90-day mortality in critically ill patients requiring fluid&#xD;
      resuscitation when compared with the same treatment using 0.9% sodium chloride (saline)&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Fluid resuscitation is a fundamental component of the management of acutely and critically&#xD;
      ill patients and the choice of fluid is a longstanding issue of debate.&#xD;
&#xD;
      Worldwide, 0.9% saline has traditionally been the most widely used resuscitation fluid,&#xD;
      however its use is increasingly challenged by emerging evidence that suggests its high&#xD;
      chloride content may have clinically important adverse effects and that resuscitation with&#xD;
      so-called &quot;balanced&quot; or &quot;buffered&quot; crystalloids (such as Plasma-Lyte 148®) offer patients&#xD;
      better outcomes.&#xD;
&#xD;
      Given the limitations of current evidence, there is now a scientific, ethical and health&#xD;
      economic imperative to provide an accurate and reliable estimate of the comparative risks&#xD;
      versus benefit of Plasma-Lyte 148® versus 0.9% saline.&#xD;
&#xD;
      The PLUS study is a prospective, multi-centre, parallel group, concealed, blinded,&#xD;
      randomised, controlled trial.&#xD;
&#xD;
      The study will test the hypothesis that in a heterogeneous population of critically ill&#xD;
      adults, random assignment to Plasma-Lyte 148® for intravascular volume resuscitation and&#xD;
      crystalloid fluid therapy in the Intensive Care Unit (ICU) results in different 90-day&#xD;
      all-cause mortality when compared with random assignment to 0.9% sodium chloride (saline) for&#xD;
      the same treatment.&#xD;
&#xD;
      Each patient who meets all inclusion criteria and no exclusion criteria will be randomised to&#xD;
      receive either Plasma-Lyte 148® or 0.9% saline for all resuscitation episodes and for all&#xD;
      compatible crystalloid therapy while in ICU for up to 90 days after randomisation. Other&#xD;
      crystalloid fluids may be used as carrier fluids for the infusion of any drug for which&#xD;
      either Plasma-Lyte 148® or 0.9% saline is considered incompatible.The study treatments will&#xD;
      be supplied in identical 1000 ml bags and treatment assignment will be concealed.&#xD;
&#xD;
      The volume of study fluid being administered will be titrated against clinical endpoints&#xD;
      determined by the treating clinicians and reviewed as clinically appropriate during the&#xD;
      period of resuscitation and ICU treatment.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2017</start_date>
  <completion_date type="Actual">June 30, 2021</completion_date>
  <primary_completion_date type="Actual">March 30, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Death from all causes</measure>
    <time_frame>At 90 days after randomisation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean and peak serum creatinine concentration</measure>
    <time_frame>First seven days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU, hospital and 28 day all-cause mortality</measure>
    <time_frame>28 days and 6 months after randomisation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of ICU stay</measure>
    <time_frame>28 days and 90 days after randomisation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of Hospital stay</measure>
    <time_frame>28 days and 90 days after randomisation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients newly treated with renal replacement therapy</measure>
    <time_frame>up to 90 days after randomisation.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of mechanical ventilation in ICU</measure>
    <time_frame>90 days after randomisation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients treated with and duration of treatment with vasoactive drugs</measure>
    <time_frame>90 days after randomisation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life assessment using the EQ-5D-5L questionnaire</measure>
    <time_frame>At 6 months after randomisation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximum post-randomisation increase in serum creatinine in ICU during the index hospital admission.</measure>
    <time_frame>90 days after randomisation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Healthcare services usage during the six months after randomisation by healthcare record linkage using state and national data linkage units</measure>
    <time_frame>During the six months after randomisation</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">5037</enrollment>
  <condition>Hypovolemia</condition>
  <arm_group>
    <arm_group_label>Plasma-Lyte 148®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Following randomisation, each study participant will receive either Plasma-Lyte 148® or 0.9% saline alone for all resuscitation episodes and for all compatible intravenous crystalloid therapy while in ICU (for up to 90 days).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>0.9% sodium chloride</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Following randomisation, each study participant will receive either Plasma-Lyte 148® or 0.9% saline alone for all resuscitation episodes and for all compatible intravenous crystalloid therapy while in ICU (for up to 90 days).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Plasma-Lyte 148®</intervention_name>
    <description>Plasma-Lyte 148 (approx pH 7.4) IV infusion is a sterile, clear nonpyrogenic isotonic solution &amp; when administered intravenously it is a source of water, electrolytes &amp; calories. Plasma-Lyte 148 intravenous infusion is indicated as a source of water &amp; electrolytes or as an alkalinising agent.</description>
    <arm_group_label>Plasma-Lyte 148®</arm_group_label>
    <other_name>Balanced crystalloid solution</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.9% sodium chloride</intervention_name>
    <description>The active ingredient is sodium chloride formulated in Water for Injections. The chemical name is sodium chloride with molecular formula NaCl. Sodium Chloride (0.9%) intravenous infusion preparation is a sterile &amp; non-pyrogenic solution &amp; is indicated for extracellular fluid replacement &amp; in the management of metabolic alkalosis in the presence of fluid loss, &amp; for restoring or maintaining the concentration of sodium &amp; chloride ions. As sodium chloride intravenous infusion is administered to the systemic circulation by intravenous infusion, the bioavailability (absorption) of the active components is complete (100 per cent).</description>
    <arm_group_label>0.9% sodium chloride</arm_group_label>
    <other_name>Saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The patient will receive fluid resuscitation defined as a bolus of fluid, prescribed&#xD;
             to be administered over one hour or less to increase or maintain intravascular volume&#xD;
             that is in addition to maintenance fluids, or specific fluids used to replace&#xD;
             non-physiological fluid losses&#xD;
&#xD;
          -  The patient is expected to be in the ICU the day after tomorrow&#xD;
&#xD;
          -  The patient is not expected to be well enough to be eating tomorrow&#xD;
&#xD;
          -  An arterial or central venous catheter is in situ, or placement is imminent as part of&#xD;
             routine management&#xD;
&#xD;
          -  Both Plasma-Lyte 148® and 0.9% saline are considered equally appropriate for the&#xD;
             patient&#xD;
&#xD;
          -  The requirement for fluid resuscitation is supported by at least one of seven&#xD;
             pre-specified clinical signs: heart rate &gt; 90 beats per minute; systolic blood&#xD;
             pressure &lt; 100 mmHg or mean arterial pressure &lt; 75 mmHg; central venous pressure &lt; 10&#xD;
             mmHg; pulmonary artery wedge pressure &lt; 12 mmHg; capillary refill time &gt; 1 second; OR&#xD;
             urine output &lt; 0.5 ml/kg for at least one hour&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age less than 18 years&#xD;
&#xD;
          -  Patients who have received more than 500mls of fluid resuscitation (as defined above)&#xD;
             prescribed in the ICU during this current ICU admission&#xD;
&#xD;
          -  Patients transferred directly from another ICU who have received more than 500mls of&#xD;
             fluid resuscitation (as defined above) during that ICU admission&#xD;
&#xD;
          -  Contraindication to either study fluid e.g. previous allergic reaction to Plasma-Lyte&#xD;
             148®&#xD;
&#xD;
          -  Patients admitted to the ICU with specific fluid requirements: the treatment of burns;&#xD;
             following liver transplantation surgery; for correction of specific electrolyte&#xD;
             abnormalities&#xD;
&#xD;
          -  Patients with traumatic brain injury or those considered at risk of developing&#xD;
             cerebral oedema&#xD;
&#xD;
          -  Patients in whom death is deemed imminent and inevitable&#xD;
&#xD;
          -  Patients with an underlying disease process with a life expectancy of &lt;90 days&#xD;
&#xD;
          -  Patients in whom it is unlikely the primary outcome can be ascertained&#xD;
&#xD;
          -  Patients who have previously been enrolled in PLUS&#xD;
&#xD;
          -  Known or suspected pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Simon Finfer, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>The George Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Blacktown Hospital</name>
      <address>
        <city>Blacktown</city>
        <state>New South Wales</state>
        <zip>2148</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Prince Alfred Hospital</name>
      <address>
        <city>Camperdown</city>
        <state>New South Wales</state>
        <zip>2050</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Sutherland Hospital</name>
      <address>
        <city>Caringbah</city>
        <state>New South Wales</state>
        <zip>2229</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Concord Repatriation General Hospital</name>
      <address>
        <city>Concord</city>
        <state>New South Wales</state>
        <zip>2139</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gosford Hospital</name>
      <address>
        <city>Gosford</city>
        <state>New South Wales</state>
        <zip>2250</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hornsby Ku-ring-gai Hospital</name>
      <address>
        <city>Hornsby</city>
        <state>New South Wales</state>
        <zip>2077</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St George Hospital</name>
      <address>
        <city>Kogarah</city>
        <state>New South Wales</state>
        <zip>2217</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Liverpool Hospital</name>
      <address>
        <city>Liverpool</city>
        <state>New South Wales</state>
        <zip>2170</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nepean</name>
      <address>
        <city>Penrith</city>
        <state>New South Wales</state>
        <zip>2751</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal North Shore Hospital</name>
      <address>
        <city>St Leonards</city>
        <state>New South Wales</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wagga Wagga Rural Referral Hospital</name>
      <address>
        <city>Wagga Wagga</city>
        <state>New South Wales</state>
        <zip>2650</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Sydney Adventist Hospital</name>
      <address>
        <city>Wahroonga</city>
        <state>New South Wales</state>
        <zip>2076</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Calvary Mater Newcastle</name>
      <address>
        <city>Waratah</city>
        <state>New South Wales</state>
        <zip>2298</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Westmead Hospital</name>
      <address>
        <city>Westmead</city>
        <state>New South Wales</state>
        <zip>2145</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wollongong Hospital</name>
      <address>
        <city>Wollongong</city>
        <state>New South Wales</state>
        <zip>2500</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Wesley Hospital</name>
      <address>
        <city>Auchenflower</city>
        <state>Queensland</state>
        <zip>4066</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Brisbane and Women's Hospital</name>
      <address>
        <city>Herston</city>
        <state>Queensland</state>
        <zip>4029</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Redcliffe Hospital</name>
      <address>
        <city>Redcliffe</city>
        <state>Queensland</state>
        <zip>4020</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Robina Hospital</name>
      <address>
        <city>Robina</city>
        <state>Queensland</state>
        <zip>4226</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mater Misericordiae</name>
      <address>
        <city>South Brisbane</city>
        <state>Queensland</state>
        <zip>4101</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gold Coast University Hospital</name>
      <address>
        <city>Southport</city>
        <state>Queensland</state>
        <zip>4215</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Toowoomba Hospital</name>
      <address>
        <city>Toowoomba</city>
        <state>Queensland</state>
        <zip>4350</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Princess Alexandra Hospital</name>
      <address>
        <city>Woolloongabba</city>
        <state>Queensland</state>
        <zip>4102</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Adelaide Hospital</name>
      <address>
        <city>Adelaide</city>
        <state>South Australia</state>
        <zip>5000</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Hobart Hospital</name>
      <address>
        <city>Hobart</city>
        <state>Tasmania</state>
        <zip>7000</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Launceston General Hospital</name>
      <address>
        <city>Launceston</city>
        <state>Tasmania</state>
        <zip>7250</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ballarat Health Services</name>
      <address>
        <city>Ballarat</city>
        <state>Victoria</state>
        <zip>3350</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bendigo Hospital</name>
      <address>
        <city>Bendigo</city>
        <state>Victoria</state>
        <zip>3550</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Box Hill Hospital</name>
      <address>
        <city>Box Hill</city>
        <state>Victoria</state>
        <zip>3128</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Monash Medical Centre</name>
      <address>
        <city>Clayton</city>
        <state>Victoria</state>
        <zip>3168</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dandenong Hospital</name>
      <address>
        <city>Dandenong</city>
        <state>Victoria</state>
        <zip>3175</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Footscray Hospital, Western Health</name>
      <address>
        <city>Footscray</city>
        <state>Victoria</state>
        <zip>3011</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Frankston Hospital</name>
      <address>
        <city>Frankston</city>
        <state>Victoria</state>
        <zip>3199</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Austin Hospital</name>
      <address>
        <city>Heidelberg</city>
        <state>Victoria</state>
        <zip>3084</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Melbourne Hospital</name>
      <address>
        <city>Parkville</city>
        <state>Victoria</state>
        <zip>3050</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maroondah Hospital</name>
      <address>
        <city>Ringwood East</city>
        <state>Victoria</state>
        <zip>3135</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sunshine Hospital, Western Health</name>
      <address>
        <city>St Albans</city>
        <state>Victoria</state>
        <zip>3021</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St John of God Murdoch Hospital</name>
      <address>
        <city>Murdoch</city>
        <state>Western Australia</state>
        <zip>6150</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fiona Stanley Hospital</name>
      <address>
        <city>Murdoch</city>
        <state>Western Australia</state>
        <zip>6165</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Shore Hospital</name>
      <address>
        <city>Takapuna</city>
        <state>Auckland</state>
        <zip>740</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rotorua Hospital</name>
      <address>
        <city>Rotorua</city>
        <state>Bay Of Plenty</state>
        <zip>3010</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hawkes Bay</name>
      <address>
        <city>Hastings</city>
        <state>Camberley</state>
        <zip>4120</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Christchurch Hospital</name>
      <address>
        <city>Christchurch</city>
        <state>Canterbury</state>
        <zip>8140</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hutt Hospital</name>
      <address>
        <city>Lower Hutt</city>
        <state>Wellington</state>
        <zip>5014</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wellington Hospital</name>
      <address>
        <city>Newtown</city>
        <state>Wellington</state>
        <zip>6021</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Auckland City Hospital (CVICU)</name>
      <address>
        <city>Auckland</city>
        <zip>1023</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Auckland City Hospital (DCCM)</name>
      <address>
        <city>Auckland</city>
        <zip>1142</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Middlemore Hospital</name>
      <address>
        <city>Auckland</city>
        <zip>1640</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Waikato Hospital</name>
      <address>
        <city>Hamilton</city>
        <zip>3240</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nelson Hospital</name>
      <address>
        <city>Nelson</city>
        <zip>7010</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tauranga Hospital</name>
      <address>
        <city>Tauranga</city>
        <zip>3110</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>New Zealand</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>March 15, 2016</study_first_submitted>
  <study_first_submitted_qc>March 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 29, 2016</study_first_posted>
  <last_update_submitted>October 20, 2021</last_update_submitted>
  <last_update_submitted_qc>October 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Plasma-Lyte</keyword>
  <keyword>Sodium chloride</keyword>
  <keyword>Saline</keyword>
  <keyword>Fluid resuscitation</keyword>
  <keyword>Intravenous fluid therapy</keyword>
  <keyword>Critically ill</keyword>
  <keyword>Critical care</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypovolemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Plasma-lyte 148</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

